{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:35:44Z","timestamp":1773221744399,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ijantimicag.2018.09.011","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T02:09:59Z","timestamp":1537150199000},"page":"74-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Synergistic and bactericidal activities of mecillinam, amoxicillin and clavulanic acid combinations against extended-spectrum \u03b2-lactamase (ESBL)-producing Escherichia coli in 24-h time\u2013kill experiments"],"prefix":"10.1016","volume":"53","author":[{"given":"Kari-Pekka","family":"Skarp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayda","family":"Shams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Montelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pernilla","family":"Lagerb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"T\u00e4ngd\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2018.09.011_bib0001","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.idc.2016.02.003","article-title":"The continuing plague of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae infections","volume":"30","author":"Adler","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijantimicag.2018.09.011_bib0002","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijantimicag.2011.09.013","article-title":"Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO\u2022SENS study revisited","volume":"39","author":"Kahlmeter","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.09.011_bib0003","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1093\/jac\/dks215","article-title":"Mecillinam\/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli","volume":"67","author":"Lampri","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.011_bib0004","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/jac\/dkt404","article-title":"Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections","volume":"69","author":"Jans\u00e5ker","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.011_bib0005","doi-asserted-by":"crossref","first-page":"e85889","DOI":"10.1371\/journal.pone.0085889","article-title":"High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli","volume":"9","author":"S\u00f8raas","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2018.09.011_bib0006","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/jac\/dki451","article-title":"Activity of mecillinam against ESBL producers in vitro","volume":"57","author":"Thomas","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.011_bib0007","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1128\/AAC.9.4.589","article-title":"In vivo synergy between 6 \u03b2-amidinopenicillanic acid derivatives and other antibiotics","volume":"9","author":"Grunberg","year":"1976","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.011_bib0008","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/archinte.168.17.1897","article-title":"Community infections caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli","volume":"168","author":"Rodr\u00edguez-Ba\u00f1o","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2018.09.011_bib0009","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and\/or epidemiological importance. Version 1.0, 2013. http:\/\/www.eucast.org [accessed 15 August 2018]."},{"key":"10.1016\/j.ijantimicag.2018.09.011_bib0010","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 8.1, 2018. http:\/\/www.eucast.org [accessed 15 August 2018]."},{"key":"10.1016\/j.ijantimicag.2018.09.011_bib0011","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1093\/jac\/dks261","article-title":"Identification of acquired antimicrobial resistance genes","volume":"67","author":"Zankari","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.011_bib0012","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Methods for determining bactericidal activity of antimicrobial agents; approved guideline. CLSI document M26-A. Wayne, PA: 1999."},{"key":"10.1016\/j.ijantimicag.2018.09.011_bib0013","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/jac\/dkx087","article-title":"A combination of mecillinam and amoxicillin\/clavulanate can restore susceptibility of high-level TEM-1-producing Escherichia coli to mecillinam","volume":"72","author":"Birgy","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl B","key":"10.1016\/j.ijantimicag.2018.09.011_bib0014","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/3.suppl_B.13","article-title":"The mechanism of action of mecillinam","volume":"3","author":"Spratt","year":"1977","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.011_bib0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1523-5378.2006.00398.x","article-title":"Multiple mutations in or adjacent to the conserved penicillin-binding protein motifs of the penicillin-binding protein 1A confer amoxicillin resistance to Helicobacter pylori","volume":"11","author":"Gerrits","year":"2006","journal-title":"Helicobacter"},{"key":"10.1016\/j.ijantimicag.2018.09.011_bib0016","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1128\/AAC.04819-14","article-title":"Amdinocillin (mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli","volume":"59","author":"Thulin","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.011_bib0017","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1469-0691.2004.00737.x","article-title":"Urinary concentrations and urine ex-vivo effect of mecillinam and sulphamethizole","volume":"10","author":"Kerrn","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2018.09.011_bib0018","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.clinthera.2005.07.001","volume":"27","author":"Ponte","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijantimicag.2018.09.011_bib0019","series-title":"Antimicrobial agents: antibacterials and antifungals","first-page":"113","article-title":"Penicillins","author":"Bryskier","year":"2005"},{"key":"10.1016\/j.ijantimicag.2018.09.011_bib0020","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/AAC.22.3.353","article-title":"Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination","volume":"22","author":"Adam","year":"1982","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791830270X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791830270X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:32:56Z","timestamp":1760376776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485791830270X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S092485791830270X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.09.011","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic and bactericidal activities of mecillinam, amoxicillin and clavulanic acid combinations against extended-spectrum \u03b2-lactamase (ESBL)-producing Escherichia coli in 24-h time\u2013kill experiments","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}